The application of plasmonicenhanced Raman imaging of cancer cells and drug delivery is gaining momentum. Here, we propose a new theranostic strategy based on an efficient plasmonic-tunable Raman/Fourier transform infrared (FTIR) spectroscopy imaging, to simultaneously evaluate the anticancer drug scattering cellular imaging and the Raman scattering molecular vibration signals in living cells. This technique allows to monitoring the drug release throughout the cell cycle and in vivo biodistribution and biocompatibility with low dose drug therapy (200 µg/mL) and low toxicity effect. This system can directly track in real-time the delivery and release of an anticancer drug (mitoxantrone, MTX) from gold nanostars in single
living cells and in mice (healthy and lung cancer mice models), revealing a strong accumulation in the heart of healthy mice 5 minutes after administration and infiltration in the tumor site of lung cancer mice 5 hours after systemic injection. This in vivo SERS detection method holds a great promise for application in image-guided cancer chemotherapy or as a nonspecific anti-inflammatory therapy for patients with cardiovascular diseases or chronic heart failure. rug delivery systems using nanomaterials have been widely used to improve drug efficiency, reducing the dosage and minimizing side effects. 1, 2 However, not every drug can be successfully conjugated, tracked and delivered into target organism. For example, pharmacokinetic analyses of nanoparticles conjugated with an anticancer drug such as doxorubicin do not give information about the position, area, and size of drugs within tissue due to cell toxicity and its fluorescence wavelength overlaps with the tissue. 12 Owing to their biocompatibility, feasible surface modification and tiny size, gold nanoparticles (GNPs) have been used for drug delivery, tumor targeting, gene therapy and photothermal therapy. [5] [6] [7] [8] [9] [10] [11] However, Raman signals are inherently weak for in vivo imaging and drug location tracking. GNPs can provide broad wavelength for Raman scattering. Since it is a challenge to avoid auto-fluorescence and minimize light absorption from tissue, one way to amplify weak Raman signals is to employ Surface-enhanced Raman spectroscopy (SERS) using sharp ending metal surfaces, such as nanostars. 5 As a result of utilizing different shape plasmonic-enhanced Raman signal from anticancer drugs, it has been possible to obtain a real-time cellular imaging of cancer cells.
Recently, our group has developed a protocol to synthesize gold nanostars to enhance the Raman signal using SERS. 13 We found that it is necessary to optimize several conditions and physical properties of nanostars to visualize anticancer drugs inside cancer cells and organs.
By optimizing these conditions gold nanostars can tune the wavelength of gold nanospheres from 560nm to the range between ultraviolet and infrared regions. 14, 15 For example, Hirsch et D al. have employed nanoshells to tune a wavelength of gold nanoparticles at 720 nm to achieve photothermal ablation of tumor cells by irradiation using near-infrared laser light in vivo. 16 Gold nanostars, star-shaped gold nanoparticles, have exceptional optical properties. [17] [18] [19] [20] They display two surface plasmon bands consistent to the transverse and longitudinal surface plasmon bands in the visible (520 nm) and the near-infrared regions, respectively 15 Thus, gold nanostars are special materials with an intense surface plasmon band that affords absorption, fluorescence [21] [22] [23] and light scattering 24, 25 in the near-infrared region, inducing two-photon luminescence phenomena. 26 Hexadecyltrimethylammonium bromide (CTAB) is a common material for gold nanostar synthesis. CTAB provides a cationic detergent to stabilizing agent during the preparation of gold nanostars. 27 The disadvantage of using CTAB method, the toxicity is not only come from CTAB, but also from silver ions. 28 Reducing concentration of CTAB during synthesis will cause the aggregation of nanostar. HEPES buffers (3-[4-(2-hydroxyethyl)piperazine-1yl]propane-1-sulphonic acid) have been used commonly used in cell culture and work as a functional reducing agent to directly change the shape of spherical gold nanoparticles to star shape. 29 Using this method we were able to produce three-dimensional branched gold nanostars and drug-nanostars.
In the present work, we proposed a new theranostics strategy using Raman/FTIR imaging spectroscopy to track in real-time the delivery and release of an anticancer drug from nanostars in living cells and their biodistribution in vivo. Mitoxantrone (MTX) 12 was conjugated to the surface of gold nanostars via a thiolated and carboxylated poly(ethylene glycol) (PEG) spacer that was attached by one-step ligand exchange and that provided the anchoring moieties for the covalent binding of amine-containing molecules like the MTX through carbodiimide chemistry (EDC/NHS coupling). MTX is a hydrophobic drug, slightly soluble in water, but with a high solubility in lipids as previously demonstrated. 30 With a lipid/water partitioning coefficient of around 230,000, it is rational to undertake that MTX crosses the plasma membrane at a high rate. 31 The MTX is an anticancer drug with significant clinical activity. Furthermore, MTX has antiviral, antibacterial, antiprotozoal, immunomodulating, and antineoplastic properties and is mutagenic in some animal systems. 32 Moreover, MTX has a red fluorescence emission as well as a strong Raman scattering signal with gold nanoparticles. The Raman signals of MTX molecules were evaluated by the plasmonic field of GNPs, depending on the distance between the drug molecules and the nanoparticle's surface. This technique allowed the simultaneous detection of the anticancer drug scattering cellular imaging and the biomolecules in living cells and in two mice models  heart tissue imaging and drug accumulation in healthy mice and tumor imaging in a lung cancer mice model (see Figure 1 ). Therefore, gold nanostars can be used as a theranostic platform for efficient intracellular and in vivo SERS detection combined with real-time drug delivery using Raman/FTIR imaging, especially for image-guided cancer chemotherapy or other diseases.
Figure 1. Gold Nanostars for theranostics: intracellular and in vivo SERS detection combined with real-time drug delivery using plasmonic-tunable Raman/FTIR imaging.
This system can directly track in real-time the delivery and release of an anticancer drug (mitoxantrone -MTX) from gold nanostars in single living cells and in mice (healthy and lung cancer mice models). This in vivo SERS detection method holds a great promise for application in image-guided cancer chemotherapy or as a nonspecific anti-inflammatory therapy for patients with cardiovascular diseases or chronic heart failure.
RESULTS AND DISCUSSION
The application of plasmonic-enhanced Raman signal from an anticancer drug conjugated to gold nanostars in real-time imaging of cancer cells and drug delivery is gaining momentum. 12 In order to enhance pharmacokinetic analyses of nanoparticles conjugated with an anticancer drug, gold nanostars were employed in the current study. 6 The gold nanostars were synthesized via seed mediated route using HEPES buffer and conjugated with a thiolated and carboxylated poly(ethylene glycol) (PEG) spacer that provided the functional groups for the covalent binding of amine-containing MTX (2 amine groups) through carbodiimide chemistry (EDC/NHS coupling) (Figure 2A) . See supporting information for detailed description about the functionalization and quantification of PEG and MTX on the surface of the nanostars (Supporting Information Figures S1-S2 and Table S1 ).
BIOMATERIALS
Briefly, The final PEG:Nanostar molar ratio was around 600:1 and the MTX:Nanostar was 100:1 (see Table S1 , Supporting Information).
Electron microscopy was employed to confirm the change in the dynamic light scattering profile of the nanospheres. More importantly, the stability of the gold nanostars solution with and without MTX functionalization was tested and remained stable up to one month in 4ºC. The hydrodynamic particle size and zeta potentials of the nanostars, as well as their SPR peaks were measured during 30 days ( Table 1 ). As shown in Table 1 , the size, charge and surface plasmon peaks remain stable for days with no significant changes over time. The stability of the MTXnanostars was also evaluated in the presence of increasing amounts of serum overtime with no significant effect on the MTX release from the nanostars for up to 30 days (Supporting Information Figure S3 ). Regarding the optical properties of the GNPs, drug-loaded gold nanostars showed two SPR peaks: a transverse plasmonic resonance peak at 600 nm, confirming the presence of a spherical core, and a longitudinal plasmonic resonance peak at 730 nm, confirming the presence of the branch-shaped aggregation around the spherical core (Figure 2E) . The peak at 600 nm attributes from the spherical core and the peak at 730 nm attributes the peripheral vertices. The spherical core of nanostar results in a SPR similar to the nanospheres while the multiple vertices contribute SPR in the near infrared range. 33, 34 The Raman spectra of the MTX-loaded gold nanostars under different laser lines (532, 633 and 785 nm) were also analyzed ( Figure 3A) . Since the intensity of the returned Raman signal is inversely proportional to the fourth power of the excitation wavelength, shorter wavelengths like 532 nm can provide stronger Raman scattering; however, can also cause sample fluorescence, which may interfere with Raman signal. As local field hotspots, the sharp vertices nanostars under a near infrared excitation source can eliminate sample fluorescence from most organic molecules Therefore, the best signal-to-noise ratio (SNR) for the MTX gold nanostar was observed for the laser line at 785 nm, as it largely avoids fluorescence but still returns a Raman signal sufficient to enable detection at a good SNR.
A stronger signal from MTX-nanostars inside the cells was observed when compared to the signal in the extracellular medium ( Figure 3B) . The signal is higher inside the cells once the gold nanostars are already abundant in the intracellular medium, changing the electric field distribution being the highest intensity located inside of the cell. This is a consequence of the cell containing gold nanostars acting as a focusing medium and the largest enhancement is located inside the cell. Even though different laser excitations can be in resonance inside or outside the cell, the intracellular medium containing the gold nanostars can change the spatial location of the maximum electric field providing selective amplification inside the cell. This represents a significant difference in terms of Raman spectroscopy due to the non-linear relation between Raman intensity and electric field. 35 As shown in Figure 3B These data prove that MTX-nanostars are optimal candidates for intracellular SERS detection and drug release using Raman/FTIR imaging and that behave as Raman scattering enhancers due to their tunable SPR and large number of hot spots on the surface associated sharp tips.
The results are consistent with the requirement for enhanced electric fields at hotspots associated with the vertices of star shaped nanoparticles. 13, 37 Thus, gold nanostars are unique materials with an intense surface plasmon band that affords absorption in the near-infrared region. [21] [22] [23] [24] [25] [26] To evaluate cellular uptake and biodistribution within cellular components and organelles, ultrastructural TEM images of human Caucasian lung epidermoid carcinoma cell (Calu-1 cells) further revealed that the MTX-nanostars were taken up by these cells in a larger extension than the bare nanostars, and were mainly localized in intracellular organelles (Figure 4A-B) . After 24 hours of incubation, MTX-nanostars were found in the cytoplasm, clustered or monodispersed, demonstrating their capability to cross biological membranes and shuttle the MTX drug into the cytoplasm (Figure 4B) .
Concerning biocompatibility, MTX-nanostars exhibited a reduced survival rate compared to nanostars alone. In a previous study, different shaped gold nanoparticles, such as spherical, triangular and hexagonal shaped have been investigated upon the cell survival rate of Calu-3 epithelial cells. The cytotoxicity was only observed after 72 hours following exposure of up to 1 mg/mL. In the current study, no significant (p>0.05) changes in cell viability were observed for either particle compared to the negative control at all concentrations tested (Figure 4C) . In contrast, a significant (p<0.05) loss in human Caucasian lung epidermoid carcinoma cell (Calu-1 cells) viability was found following exposure to MTX-nanostar (50% viable) for 72 hours at 1 mg/mL (Figure 4C) , when compared to negative control levels. Noticeably, Calu-1 cells remained viable for both types of particles and concentrations of up to 0.2 mg/mL after 72 hours (Figure 4D) . Further to the findings at 1 mg/mL, the loss in cell viability observed after MTX-nanostar exposure was found to be significantly different (p<0.01) to the status of the Calu-1 cells after exposure to the nanostar (Figure 4C) . Representative unprocessed FTIR and SERS maps, generated by the Spectrum image software, show spectrally averaged absorbance recorded from samples (Figure 5A) , for several time points (1, 8 and 48 hours) . This allows to detect the modification of the wavelength of laser resulting in a fingerprint of information on the drug structure release.
Nanoparticle regions are well defined in both the FTIR and SERS maps, due to their varying density and thickness. Spectra of the cells at 1, 8 and 48 hours of exposure to MTX-nanostars were extracted from the FTIR and SERS maps, evaluating the spectra of cellular structures characteristic of the cell line (see Figure 5B) . Each spectrum was calculated as an average of 30-40 signals extracted from the FTIR and SERS maps characteristic of the defined cellular structure and was subjected to pre-processing using the RMieS-EMSC algorithm. 38 The
RMieS-EMSC algorithm is used to correct the infrared spectra and remove spectral distortions from Resonant Mie Scattering of biological cells. has also reported that the distribution of anticancer drugs such as doxorubicin, mitoxantrone and topotecan from blood vessels is better in normal tissues, such as the heart and liver compared to the distribution in solid tumors. 12 In fact, the biodistribution of MTX-nanostars was also confirmed by ex vivo organ inductively coupled plasma mass spectrometry (ICP-MS) for 1 and 5 minutes after injection of the nanostars. The results show that 5 minutes after injection, MTX-nanostars are almost exclusively accumulated in the heart (consistent with the in vivo images in Figure 6A) , with no significant accumulation in most of the other tissues and organs (Supporting Information Figure S4A) . Kreyling et al. also show that nanoparticles distribute into heart at the first blood circulation and start to aggregate into lung after 4 hours. 39 Our results also supports this idea that drugs are distributed in the blood, which is likely to provide greater access to well perfused organs such as the heart, liver and lung.
Average absorbance FTIR maps also showed evidence of hotspots due to the high intensity of MTX-nanostars on the heart tissue (Figure 6C) . The color red represents region of the nanoparticle, green and light blue were the background. Hematoxylin and eosin (H&E) staining on heart tissue was shown in bright field image (Figure 6D) in accordance with the FTIR maps (Figure 6C) . The H&E staining image can only show heart histological structure, but it is not sufficient for imaging of nanoparticles or small aggregates and not specific to anticancer agents. 40 FTIR imaging does not require fixation, sectioning and staining as in Figure 6E ). The fluorescent signal on the back of the mice can be seen in Figure 6A . This data further provides evidence that MTX-nanostars biodistribution in heart and aorta is attributed to the fluorescent signal on the back side of mice (Figure 6A) .
The biodistribution and accumulation in the heart is likely to be more efficient due to a highly organized vascular structure and large pressure gradients across the endothelial membrane. 12 These results confirm this method as a great promise for application as a nonspecific antiinflammatory therapy for patients with cardiovascular diseases or chronic heart failure. In fact, MTX has also been used with success as a nonspecific anti-inflammatory therapy for patients with cardiovascular diseases or chronic heart failure. 41 Concerning the in vivo SERS detection in a lung cancer mice model, we were able to image the characteristic SERS peaks and signal accumulated on the lung tumors of mice treated with MTX nanostars. The C57BL/6 mice bearing human Calu-1 xenograft lung tumor (3-mm diameter) received 0.2 mL (200 µg/mL) of MTX nanostars. The MTX nanostars were administered in a single injection via tail vein. SERS spectra were taken 5 hours after injection. SERS measurements from the tumor tissue revealed the presence of MTX-nanostars (Figure 7) . In order to test the development of the lung tumor in mice, bioluminescence imaging was carried out to serially assess lung tumor in each mouse treated with MTXnanostars, with luciferase activity as a measure for tumor burden (Figure 7A) .
In order to track MTX-nanostars in tumor and lung tissues plasmonic-tunable Raman/FITR imaging spectroscopy was used (Figure 7B) . The cancer tissue was under processed with standard cryosection steps using regular histology methodologies. The sections were cut and spread on 2 mm CaF2 substrate, without any chemical treatment, in order to prevent any further chemical modification. Figure 7B shows the FTIR image of MTX-nanostars accumulated on lung tissue, revealing several tumoral clones in the lung. With this method we are able to image each individualized tumor in the lungs (arrows in Figure 7B ). Imaging the lung tissue at different time points revealed that MTX-nanostars are uniformly distributed inside lung tissue and tumor at 5 hours after administration (Figure 7D) , whereas ate 0.5 hours is still mainly around the tumor microenvironment ( Figure 7C) .
This experiment confirms the SERS signal in vivo and specificity of our MTX-nanostars.
SERS mapping results confirms that MTX-nanostars are distributed more or less uniformly throughout the area of interest in the tumor tissue ( Figure 7E ). SERS mapping using characteristic peak (Figure 7F) can reveal the localization and distribution of the MTXnanostars throughout the anatomical location of the lung tumor tissue.
The biodistribution of MTX-nanostars was also confirmed by ex vivo organ inductively coupled plasma mass spectrometry (ICP-MS) for 0.5 and 5 hours after injection of the nanostars. The results show that 5 hours after injection, MTX-nanostars are mainly accumulated in the lung (tumor), with less accumulation in most of the other tissues and major organs, especially in the heart, liver and kidney (Supporting Information Figure S4B ). 
Functionalization of HEPES-buffered gold nanostar through conjugation with PEG and
Mitoxantrone. For the all functionalization steps and quantification assays of the nanostars with the PEG, can be found in Supplementary information.
Characterization of functionalized gold nanostars. The stability of the gold nanostars solution was tested for up to one month in 4ºC according to proceed. 13 The diameter, Zeta Potential and Surface Plasmon Resonance peaks of the zeta potentials of the nanostars with and without MTX are depicted in Table 1 .
Raman spectroscopy. Raman spectroscopy was performed with a HORIBA Jobin Yvon HR800 spectrometer with 532 nm, 632 nm, and 785 nm diode laser as source according to proceed. 13 Spectral data were collected using a 10× microscope objective over the range 400-1800 cm −1 with a 10 sec integration time. Cell viability assay. Nanostar and MTX-nanostars biocompatibility was evaluated in an epithelial cell line (Calu-1) over period 6 to 72 hours. In the WST-1 assay, cells were seeded on microplates at a concentration 4000 cell/well in 100µl culture medium containing GNPs. Different concentration of gold nanoparticle was loaded in the microplates at concentrations ranging from 0.0001-1 mg/mL. The cells were incubated for 6, 12, 24, 48 and 72 hours at 37°C and 5% CO2 after adding GNPS. A 10 µl/well cell proliferation reagent WST-1 was mixture with cell medium and incubated for 4 h at 37°C and 5% CO2. The samples were measured at the absorbance wavelength of 450 nm. A triplicate analysis was performed from three independent experiments (n=3).
In vitro application of Raman Spectroscopy. Calcium Fluoride (CaF2) substrate was immersed in virkon for a few hours or overnight before plating the cells. The substrate was washed using sterilized water and placed in a small petri dish. Calu-1 cells were trypsinised and counted. A sufficient amount (approximately 500 µL) of cells suspension was added to cover the substrate. The dish was incubated in CO2 incubator for 3 hours. A fresh media (with 10% Fetal bovine serum, FBS) with nanostar was added to the 3 cm petro dish and the plates at final concentration of 0.2 mg/mL MTX-nanostars were left to be incubated for a period of 1, 4, 8, 24, 48 and 72 hours. After the incubation period, the media in the dish is discarded and washed away using Phosphate buffered saline (PBS buffer). 3 mL of PBS buffer was added into the plate and the plate is ready to be measured using Raman spectroscopy.
Confocal microscopy imaging. Calu-1 cells were seeded at a density of 1×10 4 cells/cm 2 and treated with 0.2 mg/mL MTX-nanostars in 3 cm petro dish for 24, 48 and 72 hours. Samples were then imaged by laser scanning microscopy (Carl Zeiss 510, at a 400× magnification).
With each time points, four images per sample were captured to gain a representative understanding of drug location in Calu-1 epithelial cells following MTX-nanostars exposure.
FTIR Instrumentation. Six different cell samples and tissue slides samples were seed on the CaF2 crystal substrate to recording NIR spectra. NIR spectra were recorded with the Perkin Elmer Spotlight 400N Universal Attenuated Total Reflectance (UATR) accessory of the spectrometer. The spectral data were the result of 4 scans, with a spectral resolution of 8 cm -1 .
Dynamic distribution of nanostar-MTX in mice. In order to better understand and predict drug effects and toxicities, drug distribution in time and location were recorded to complement pharmacokinetic data Briefly, MTX-nanostars (0.2 mL, 10 mg/kg) were injected into mice through the vena caudalis after chloroform inhalation. NIR imaging system equipped with a 765 nm laser as excitation source was employed to trace the distribution of the nanostar-MTX. The background image of the mice was taken prior to the injection. Due to a significant decrease in drug fluorescence after administration, a series of images were collected at 1, 2, 3 and 5 minutes post-injection respectively. All animal experiments were approved by the Institutional Animal Care and Use Committee of Shanghai Jiao Tong University (NO.SYXK2007-0025). The background fluorescence that was measured before injection was subtracted from the post injection fluorescence. In order to confirm the biodistribution of the nanostar in living mice, some major organs (heart, liver, spleen, lung, kidney, intestine of the subject mice were excised at 5 min post-injection and detected by NIR fluorescence imaging system.
Histology and immunolocalisation. After mice have been sacrificed and perfused with sterile PBS, heart, aorta and skin located at the back of mice with highest fluorescent intensity point under NIR imaging were snap-frozen in optimum cutting temperature compound (Tissue-Tek®) and cut on a cryostat microtome. Frozen sections were stained for hematoxylin and eosin using standard procedures. Stained tissue sections were then imaged by light microscopy. For immunolocalisation, the tissues sections were stained with a green phalloidin probe (Invitrogen) at a 1:40 dilution. Subsequently tissues were then imaged by ZEISS Confocal scanning microscopy at laser line 488 nm and 514 nm.
In vivo SERS. MTX-nanostars (0.2 mL, 10 mg/kg) were injected into mice through the vena caudalis. The lung cancer tissue was directly carried out Raman imaging, and the flat area in the tissue was attractive candidate. Raman imaging was carried out in a LabRAM HR Evolution spectrometer (Horiba Scientific,) with a computer-controlled x,y stage in a 5 μm step size at 633 nm excitation, using a 10× objective with a detection range from 1000-1600 cm −1 . The excitation intensity and accumulation time was 5 mW and 2 s, respectively.
